Literature DB >> 10644592

Voltage-dependent facilitation of cardiac L-type Ca channels expressed in HEK-293 cells requires beta-subunit.

T J Kamp1, H Hu, E Marban.   

Abstract

The activity of native L-type Ca channels can be facilitated by strong depolarizations. The cardiac Ca channel alpha(1C)-subunit was transiently expressed in human embryonic kidney (HEK-293) cells, but these channels did not exhibit voltage-dependent facilitation. Coexpression of the Ca channel beta(1a)- or beta(2a)-subunit with the alpha(1C)-subunit enabled voltage-dependent facilitation in 40% of cells tested. The onset of facilitation in alpha(1C) + beta(1a)-expressing HEK-293 cells was rapid after a depolarization to +100 mV (tau = 7.0 ms). The kinetic features of the facilitated currents were comparable to those observed for voltage-dependent relief of G protein inhibition demonstrated for many neuronal Ca channels; however, intracellular dialysis with guanosine 5'-O-(2-thiodiphosphate) and guanosine 5'-O-(3-thiotriphosphate) in the patch pipette had no effect on facilitation. Stimulation of G protein-coupled receptors, either endogenous (somatostatin receptors) or coexpressed (adenosine A(1) receptors), did not affect voltage-dependent facilitation. These results indicate that the cardiac Ca channel alpha(1C)-subunit can exhibit voltage-dependent facilitation in HEK-293 cells only when coexpressed with an auxiliary beta-subunit and that this facilitation is independent of G protein pathways.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10644592     DOI: 10.1152/ajpheart.2000.278.1.H126

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  8 in total

1.  The beta1a subunit regulates the functional properties of adult frog and mouse L-type Ca2+ channels of skeletal muscle.

Authors:  Rubén García; Elba Carrillo; Santiago Rebolledo; María C García; Jorge A Sánchez
Journal:  J Physiol       Date:  2002-12-01       Impact factor: 5.182

2.  Modulation of the gating of unitary cardiac L-type Ca(2+) channels by conditioning voltage and divalent ions.

Authors:  Ira R Josephson; Antonio Guia; Edward G Lakatta; Michael D Stern
Journal:  Biophys J       Date:  2002-11       Impact factor: 4.033

3.  Cytoskeletal disrupting agents prevent calmodulin kinase, IQ domain and voltage-dependent facilitation of L-type Ca2+ channels.

Authors:  Igor Dzhura; Yuejin Wu; Roger J Colbran; Jackie D Corbin; Jeffrey R Balser; Mark E Anderson
Journal:  J Physiol       Date:  2002-12-01       Impact factor: 5.182

4.  CaMKII associates with CaV1.2 L-type calcium channels via selected beta subunits to enhance regulatory phosphorylation.

Authors:  Sunday A Abiria; Roger J Colbran
Journal:  J Neurochem       Date:  2009-10-15       Impact factor: 5.372

5.  Functional properties of the CaV1.2 calcium channel activated by calmodulin in the absence of alpha2delta subunits.

Authors:  Arippa Ravindran; Evgeny Kobrinsky; Qi Zong Lao; Nikolai M Soldatov
Journal:  Channels (Austin)       Date:  2009-01-25       Impact factor: 2.581

6.  C terminus L-type Ca2+ channel calmodulin-binding domains are 'auto-agonist' ligands in rabbit ventricular myocytes.

Authors:  Igor Dzhura; Yuejin Wu; Rong Zhang; Roger J Colbran; Susan L Hamilton; Mark E Anderson
Journal:  J Physiol       Date:  2003-06-13       Impact factor: 5.182

7.  Increased expression of the auxiliary beta(2)-subunit of ventricular L-type Ca(2)+ channels leads to single-channel activity characteristic of heart failure.

Authors:  Roger Hullin; Jan Matthes; Sibylle von Vietinghoff; Ilona Bodi; Marta Rubio; Karen D'Souza; Ismail Friedrich Khan; Dennis Rottländer; Uta C Hoppe; Paul Mohacsi; Eva Schmitteckert; Ralf Gilsbach; Moritz Bünemann; Lutz Hein; Arnold Schwartz; Stefan Herzig
Journal:  PLoS One       Date:  2007-03-14       Impact factor: 3.240

8.  Apamin does not inhibit human cardiac Na+ current, L-type Ca2+ current or other major K+ currents.

Authors:  Chih-Chieh Yu; Tomohiko Ai; James N Weiss; Peng-Sheng Chen
Journal:  PLoS One       Date:  2014-05-05       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.